Granagard administration prolongs the survival of human mesenchymal stem cells transplanted into a mouse model of multiple sclerosis
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved..
The clinical effect of human Mesenchymal stem cells (hMSCs) transplanted into EAE mice/MS patients is short lived due to poor survival of the transplanted cells. Since Granagard, a nanoformulation of pomegranate seed oil, extended the presence of Neuronal Stem cells transplanted into CJD mice brains, we tested whether this safe food supplement can also elongate the survival of hMSCs transplanted into EAE mice. Indeed, pathological studies 60 days post transplantation identified human cells only in brains of Granagard treated mice, concomitant with increased clinical activity. We conclude that Granagard may prolong the activity of stem cell transplantation in neurological diseases.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:389 |
|---|---|
| Enthalten in: |
Journal of neuroimmunology - 389(2024) vom: 15. Apr., Seite 578313 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Frid, Kati [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
EAE |
|---|
| Anmerkungen: |
Date Completed 08.04.2024 Date Revised 08.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jneuroim.2024.578313 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368913740 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368913740 | ||
| 003 | DE-627 | ||
| 005 | 20240408232431.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jneuroim.2024.578313 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1369.xml |
| 035 | |a (DE-627)NLM368913740 | ||
| 035 | |a (NLM)38401393 | ||
| 035 | |a (PII)S0165-5728(24)00031-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Frid, Kati |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Granagard administration prolongs the survival of human mesenchymal stem cells transplanted into a mouse model of multiple sclerosis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.04.2024 | ||
| 500 | |a Date Revised 08.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a The clinical effect of human Mesenchymal stem cells (hMSCs) transplanted into EAE mice/MS patients is short lived due to poor survival of the transplanted cells. Since Granagard, a nanoformulation of pomegranate seed oil, extended the presence of Neuronal Stem cells transplanted into CJD mice brains, we tested whether this safe food supplement can also elongate the survival of hMSCs transplanted into EAE mice. Indeed, pathological studies 60 days post transplantation identified human cells only in brains of Granagard treated mice, concomitant with increased clinical activity. We conclude that Granagard may prolong the activity of stem cell transplantation in neurological diseases | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a EAE | |
| 650 | 4 | |a Granagard | |
| 650 | 4 | |a MS | |
| 650 | 4 | |a Mesenchymal | |
| 650 | 4 | |a Stem cells | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 700 | 1 | |a Usmann, Areen |e verfasserin |4 aut | |
| 700 | 1 | |a Markovits-Pachter, Tsipora |e verfasserin |4 aut | |
| 700 | 1 | |a Binyamin, Orli |e verfasserin |4 aut | |
| 700 | 1 | |a Petrou, Panayota |e verfasserin |4 aut | |
| 700 | 1 | |a Kassis, Ibrahim |e verfasserin |4 aut | |
| 700 | 1 | |a Karussis, Dimitri |e verfasserin |4 aut | |
| 700 | 1 | |a Gabizon, Ruth |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of neuroimmunology |d 1985 |g 389(2024) vom: 15. Apr., Seite 578313 |w (DE-627)NLM012614181 |x 1872-8421 |7 nnns |
| 773 | 1 | 8 | |g volume:389 |g year:2024 |g day:15 |g month:04 |g pages:578313 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jneuroim.2024.578313 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 389 |j 2024 |b 15 |c 04 |h 578313 | ||